Literature DB >> 1382144

Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions.

M Kutubuddin1, J Simons, M Chow.   

Abstract

A major histocompatibility complex (MHC) class I-restricted cytotoxic T-lymphocyte (CTL) response is induced in BALB/c mice upon immunization with poliovirus serotype 1 (Mahoney strain). A similar class I-restricted response is also induced upon immunization with purified VP1 capsid proteins. Thus, poliovirus-specific MHC class I CTL responses can be induced independently of viral infection in murine hosts. In experiments using recombinant vaccinia virus vectors expressing different segments of the poliovirus capsid proteins and synthetic peptides, two regions of the VP1 capsid protein appear to contain epitopes recognized by this bulk CTL population. These epitope regions contain a Kd-restricted peptide-binding motif. Interestingly, each of these CTL epitopes is located near previously defined neutralizing antigenic sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382144      PMCID: PMC241474     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

2.  Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.

Authors:  L Akerblom; J Hinkula; P A Broliden; B Mäkitalo; T Fridberger; J Rosen; M Villacres-Eriksson; B Morein; B Wahren
Journal:  AIDS       Date:  1990-10       Impact factor: 4.177

3.  Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1.

Authors:  C Leclerc; E Deriaud; V Mimic; S van der Werf
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

4.  Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus.

Authors:  M D Lindsley; R Thiemann; M Rodriguez
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.

Authors:  J Y Wu; B H Gardner; C I Murphy; J R Seals; C R Kensil; J Recchia; G A Beltz; G W Newman; M J Newman
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

6.  Identification of T-helper epitopes in the VP1 capsid protein of poliovirus.

Authors:  M Kutubuddin; J Simons; M Chow
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.

Authors:  M J Newman; J Y Wu; B H Gardner; K J Munroe; D Leombruno; J Recchia; C R Kensil; R T Coughlin
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

8.  Murine monoclonal antibodies directed against the transmembrane protein gp41 of human immunodeficiency virus type 1 enhance its infectivity.

Authors:  M Niedrig; M Bröker; G Walter; W Stüber; H P Harthus; S Mehdi; H R Gelderblom; G Pauli
Journal:  J Gen Virol       Date:  1992-04       Impact factor: 3.891

9.  The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins.

Authors:  R Finberg; M Mescher; S J Burakoff
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

10.  Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.

Authors:  P Aichele; H Hengartner; R M Zinkernagel; M Schulz
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  10 in total

1.  MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A.

Authors:  S B Deitz; D A Dodd; S Cooper; P Parham; K Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Binding motifs predict major histocompatibility complex class II-restricted epitopes in the Sendai virus M protein.

Authors:  G A Cole; T Tao; T L Hogg; K W Ryan; D L Woodland
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

Review 3.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  Schistosoma mansoni phosphoenolpyruvate carboxykinase, a novel egg antigen: immunological properties of the recombinant protein and identification of a T-cell epitope.

Authors:  H Asahi; A Osman; R M Cook; P T LoVerde; M J Stadecker
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.

Authors:  A B Kulkarni; H C Morse; J R Bennink; J W Yewdell; B R Murphy
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.

Authors:  R Schirmbeck; K Melber; T Mertens; J Reimann
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen.

Authors:  S Mandl; L J Sigal; K L Rock; R Andino
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

8.  Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies.

Authors:  Z C Neal; G A Splitter
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans.

Authors:  J Simons; M Kutubuddin; M Chow
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.

Authors:  B P Mahon; K Katrak; A Nomoto; A J Macadam; P D Minor; K H Mills
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.